I think the market is evaluating BRN based on a realistic price for an eventual take over (which in turn englobes both past R&S efforts/costs and future market share/potential revenues). I truly believe that it does not any sense to try to evaluate Brainchip based on 2021 revenues. It would be stupid don't you agree?
I think the market is evaluating BRN based on a realistic price...
Add BRN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
-0.005(2.33%) |
Mkt cap ! $389.7M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.5¢ | 20.8¢ | $610.1K | 2.904M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 593140 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 560405 | 10 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| BRN (ASX) Chart |